Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24801496 | 0.94 | ESR2 (0.31) | ESR2PRKDC | |
| SCHEMBL23609618 | 0.89 | KDM4E (0.31) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL24801453 | 0.89 | PRKDC (0.32) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL24803006 | 0.88 | PRKDC (0.32) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL24801461 | 0.87 | PRKDC (0.34) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL23609724 | 0.86 | ALDH1A1 (0.33) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL24802349 | 0.85 | KDM4E (0.30) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL23609936 | 0.84 | PRKDC (0.32) | PRKDC | |
| SCHEMBL24801484 | 0.84 | LIMK1 (0.32) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL23609625 | 0.83 | CYP1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411411-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT | LT MATERIALS CO.,LTD. (KR) | 2022-12-29 | — | — | US | disclosed |
| WO-2021133016-A2 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT | 엘티소재주식회사 | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411411-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING ORGANIC LIGHT-EMITTING ELEMENT | CRY1, ODC1, ORC3 | ESR2 489/4885KDM4E 2970/4885ALDH1A1 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.